Track and Trace - Pharmaceutical Executive

ADVERTISEMENT

Track and Trace
For RFID, the devil is in the details


Pharmaceutical Executive


What should companies be thinking about today?

I think the good news is that the industry really is tuning in and participating in the key activities, like the EPCglobal Health and Life Sciences business action group. In that way, many of the industry associations have established the right forms for understanding all of the issues and challenges. I don't know that this can be any huge surprise, unless, of course, they're not participating in these types of forums, in which case there will be perhaps a very rude awakening for those who just haven't been paying attention.

As with any new technology or a change in processes in business and supply chain relationships, there come different challenges around change management, training, and organizational models. Those are the kinds of things that aren't as talked up right now as some of the other issues around technology, price performance, pedigree consistency, and authentication.

James Hintlian is the lead partner for Accenture's Health & Life Sciences Supply Chain practice, based in Boston. He currently is leading Accenture's pharmaceutical Electronic Product Code (EPC) and ePedigree industry program. He also is a special advisor to the EPCglobal in Healthcare Business Action Group, and is a member of the editorial advisory board for Supply Chain Management Review. He holds a master of engineering and an MBA.


ADVERTISEMENT

blog comments powered by Disqus
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

FindPharma Careers
Source: Pharmaceutical Executive,
Click here